Effects of tranexamic acid treatment in severely and non-severely injured trauma patients (2022)
Attributed to:
The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/trf.16954
PubMed Identifier: 35748686
Publication URI: http://europepmc.org/abstract/MED/35748686
Type: Journal Article/Review
Parent Publication: Transfusion
Issue: S1